Champions Oncology


Recent Posts

The Children’s Cancer Therapy Development Institute is Collaborating with Champions Oncology and Jackson Laboratory to provide RACEact/PREA Pediatric Cancer Study Plan Services

Jan 29, 2020 10:00:00 AM / by Champions Oncology

The Children’s Cancer Therapy Development Institute (cc-TDI), Champions Oncology, and The Jackson Laboratory offer rapid, cost-effective services to the pharma, biopharma and biotech industry– speeding the right drug to the right pediatric cancer whenever possible.

Read More →

Champions Oncology and PhenoVista Biosciences Announce a Strategic Partnership to provide Oncology Imaging-Based Phenotypic Assays for Preclinical Drug Development

Nov 13, 2019 10:00:00 AM / by Champions Oncology

Hackensack, NJ – November 13, 2019 – Champions Oncology (NASDAQ: CSBR), an end-to-end R&D Oncology solutions company announced today that they have entered into a strategic partnership with PhenoVista Biosciences.

Read More →

Champions Oncology Partners with TransCure bioServices to Expand European Business and Operations

May 30, 2019 10:00:00 AM / by Champions Oncology

HACKENSACK, NJ – May 30, 2019  –  Champions Oncology, Inc. (NASDAQ: CSBR), engaged in an end-to-end range of research and development technology solutions and services to improve the development and use of oncology drugs, today announced they have partnered with TransCure bioServices to expand the pharmacology operations of Champions’ translational oncology tools throughout Europe.

Read More →

Champions Oncology Reports Record Quarterly Revenue of $6.2 Million

Sep 13, 2018 10:00:00 AM / by Champions Oncology

Reiterates Expectations for Revenue Growth of at Least 20% for Fiscal Year 2019

 Hackensack, NJ – September 13, 2018 – Champions Oncology, Inc. (Nasdaq: CSBR), engaged in an end-to-end range of research and development technology solutions and services to improve the development and use of oncology drugs, today announced its financial results for the first fiscal quarter ended July 31, 2018.

Read More →